Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals unit lost a jury trial in Philadelphia over its drug Topamax. The jury ordered the companies to pay $11 million in a product liability lawsuit which claimed that the anti-seizure drug Topamax caused birth defects.
Jurors in state court in Philadelphia found that Janssen failed to adequately warn doctors for Haley Powell, of the risks of Topamax before she gave birth to a son with a cleft lip.